Clinical Trial Update: Alexithymia Intervention for Suicide [Phase 1]

View source ↗

Summary

Phase 1 trial of an alexithymia intervention for suicide risk was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Post-traumatic Stress Disorder
• Schizophrenia

Snippet

Sponsor: VA Office of Research and Development | Conditions: Suicide, Schizophrenia | Phase 1 | Status: TERMINATED